Clinical Trials in Chronic Lymphocytic Leukaemia (CLL)


Trial Name


Trial Summary






This trial is comparing ibrutinib alongside rituximab with fludarabine, cyclophosphamide, rituximab and venetoclax for chronic lymphocytic leukaemia. This trial is for people who haven’t yet had treatment for their chronic lymphocytic leukaemia (CLL)


More details


This trial is for patients with untreated CLL, comparing the drug BGB-3111 with bendamustine and rituximab.

More details